🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationState-by-state compounding pharmacy regulations — 2026 map Page 2

State-by-state compounding pharmacy regulations — 2026 map

RegAffairsDC Thu, Mar 12, 2026 at 7:01 AM 8 replies 266 viewsPage 2 of 2
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Mar 12, 2026 at 9:51 AM#6

This is super helpful. So the bottom line is: if I want the smoothest experience, I should find a 503B outsourcing facility that's licensed in my state, rather than trying to use a local 503A pharmacy?

Last edited: Mar 12, 2026 at 3:51 PM
11 14Dr.LipidDallas, alex_tucson, kevin_tulsa and 8 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Mar 12, 2026 at 10:08 AM#7

Generally yes, for GLP-1 peptides specifically. 503B facilities have the federal registration that smooths over most state-to-state issues. Just verify they're licensed in your state before placing an order — most will list their state licenses on their website.

And keep in mind this landscape changes constantly. What's true today might not be true in 6 months, especially with FDA enforcement actions ramping up.

42 0Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 39 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Mar 12, 2026 at 10:25 AM#8

One more thing — regardless of which state you're in, always check the FDA's list of registered outsourcing facilities. If a 503B claims to be registered but isn't on that list, that's a major red flag. The list is publicly available and searchable. Takes 2 minutes to verify. 📋

Last edited: Mar 12, 2026 at 11:25 AM
46 20tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 43 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
Beyond-use dating for compounded peptides — USP <797> compliance6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register